Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:51 PM
Ignite Modification Date:
2025-12-24 @ 11:51 PM
NCT ID:
NCT00698451
Eligibility Criteria:
Inclusion Criteria:
* Histologic diagnosis of epithelial ovarian, fallopian tube or primary peritoneal cancer
* Relapse-free interval of \>6 months afer completion of first line platinum-based chemotherapy
* Measurable disease (at least one lesion that can be accurately measured in a least 1 dimension)
* Adequate bone marrow function, renal, and liver function. Normal cardiac function
* Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1.
Exclusion Criteria:
* No patients who have received more than 1 previous regimen of chemotherapy (maintenance is not considered a second regimen)
* No patients receiving immunotherapy or radiotherapy or patients who have received prior radiotherapy to any portion of the abdominal cavity or pelvis
* No patients who require parenteral hydration or nutrition or have clinical signs or symptoms of gastrointestinal bowel obstruction or perforation
* No patients with previous or current malignancy other than basal cell or squamous cell carcinoma of the skin
* No patients with clinically significant cardiovascular disease
* No patients with a history of bevacizumab or other VEGF or VEGF receptor-targeted agent use.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT00698451
Study Brief:
Protocol Section:
NCT00698451